List of insiders holdings for Voyager Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
NEUROCRINE BIOSCIENCES INC 10% Owner | 2023-02-24 06:15:52 | 8,575,316 0 | 8,575,316 | Form 13D |
Third Rock Ventures III L.P. Third Rock Ventures GP III L.P. TRV GP III LLC STARR KEVIN P TEPPER ROBERT I 10% Owner | 2019-02-13 16:02:02 | 6,457,874 0 | 6,457,874 | Form 13G |
EcoR1 Capital LLC 10% Owner | 2023-01-13 16:33:55 | 3,851,507 0 | 3,851,507 | Form 13G |
Hadley Harbor Master Investors (Cayman) L.P. 10% Owner | 2015-11-18 21:03:20 | 470,588 0 | 470,588 | Form 4 |
Henderson Jane Sr. V.P. & CFO, Corp. Dev. | 2018-03-26 16:02:25 | 342,368 0 | 342,368 | Form 4 |
Sandrock Alfred President and CEO | 2024-04-03 16:10:41 | 322,839 0 | 322,839 | Form 4 |
Turenne Andre President & CEO | 2021-03-23 16:10:57 | 322,375 0 | 322,375 | Form 4 |
Sah Dinah Ph.D. Chief Scientific Officer | 2019-01-17 20:51:14 | 213,688 0 | 213,688 | Form 4 |
Third Rock Ventures III L.P. Third Rock Ventures GP III L.P. TRV GP III LLC TEPPER ROBERT I 10% Owner | 2024-02-14 16:19:07 | 186,423 0 | 186,423 | Form 13G |
PFREUNDSCHUH PETER P. Chief Financial Officer | 2024-02-22 16:32:59 | 175,669 0 | 175,669 | Form 4 |
Khwaja Omar See remarks | 2021-05-25 16:31:13 | 120,509 0 | 120,509 | Form 4 |
Swartz Robin Chief Operating Officer | 2024-04-03 16:13:27 | 117,004 0 | 117,004 | Form 4 |
Dorval Allison Chief Financial Officer | 2021-03-23 16:10:28 | 109,894 0 | 109,894 | Form 4 |
Ferguson Toby Chief Medical Officer | 2024-04-03 16:17:01 | 105,000 0 | 105,000 | Form 4 |
Goater Jeff Chief Financial Officer | 2016-02-02 16:03:30 | 105,000 0 | 105,000 | Form 4 |
Hesslein Robert W. Senior VP & General Counsel | 2023-03-22 16:47:41 | 102,200 0 | 102,200 | Form 4 |
Carter Todd Alfred Chief Scientific Officer | 2024-02-22 16:30:55 | 87,627 0 | 87,627 | Form 4 |
Fahey Sandell Jacquelyn Chief Legal Officer | 2024-10-03 16:43:34 | 86,001 0 | 86,001 | Form 4 |
Jorgensen Nathan D. Chief Financial Officer | 2024-10-02 16:09:19 | 80,000 0 | 80,000 | Form 4 |
Burek Julie VP, Finance | 2022-03-23 18:36:44 | 52,458 0 | 52,458 | Form 4 |
Ottmer Matthew P. Chief Operating Officer | 2020-01-29 17:26:53 | 26,276 0 | 26,276 | Form 4 |
Vitale Nancy Director | 2024-06-07 16:22:47 | 24,000 0 | 24,000 | Form 4 |
SCANGOS GEORGE A Director | 2024-06-07 16:21:53 | 24,000 0 | 24,000 | Form 4 |
PIERCE GLENN Director | 2024-06-07 16:20:49 | 24,000 0 | 24,000 | Form 4 |
Colon Grace Director | 2024-06-07 16:15:13 | 24,000 0 | 24,000 | Form 4 |
GERAGHTY JAMES A Director | 2024-06-07 16:15:45 | 24,000 0 | 24,000 | Form 4 |
Higgins Michael J Director | 2024-06-07 16:16:51 | 24,000 0 | 24,000 | Form 4 |
Hyman Steven Director | 2024-06-07 16:17:50 | 24,000 0 | 24,000 | Form 4 |
MACKEY CATHERINE J Director | 2024-06-07 16:19:25 | 24,000 0 | 24,000 | Form 4 |
Onyia Jude Director | 2024-06-07 16:20:15 | 24,000 0 | 24,000 | Form 4 |
PAUL STEVEN M Director | 2021-06-04 16:34:26 | 15,000 0 | 15,000 | Form 4 |
KARSEN PERRY A Director | 2019-06-17 19:00:36 | 15,000 0 | 15,000 | Form 4 |
DIXON WENDY L Director | 2020-06-05 16:16:36 | 15,000 0 | 15,000 | Form 4 |
LEVIN MARK J Director 10% Owner | 2021-06-04 16:32:34 | 15,000 0 | 15,000 | Form 4 |
Ravina Bernard Chief Medical Officer | 2018-04-12 16:01:23 | 0 0 | 0 | Form 4 |
Sanofi Former 10% owner | 2019-02-11 08:41:02 | 0 0 | 0 | Form 13G |